Colcher D - Search Results

1

ImmunoPET, [⁶⁴Cu]Cu-DOTA-Anti-CD33 PET-CT, Imaging of an AML Xenograft Model.

Srideshikan SM, Brooks J, Zuro D, Kumar B, Sanchez J, Echavarria Parra L, Orellana M, Vishwasrao P, Nair I, Chea J, Poku K, Bowles N, Miller A, Ebner T, Molnar J, Rosenthal J, Vallera DA, Wong JYC, Stein AS, Colcher D, Shively JE, Yazaki PJ, Hui SK. Srideshikan SM, et al. Among authors: colcher d. Clin Cancer Res. 2019 Dec 15;25(24):7463-7474. doi: 10.1158/1078-0432.CCR-19-1106. Epub 2019 Sep 23. Clin Cancer Res. 2019. PMID: 31548348 Free PMC article.

2

Diagnostic PET Imaging of Mammary Microcalcifications Using ⁶⁴Cu-DOTA-Alendronate in a Rat Model of Breast Cancer.

Ahrens BJ, Li L, Ciminera AK, Chea J, Poku E, Bading JR, Weist MR, Miller MM, Colcher DM, Shively JE. Ahrens BJ, et al. J Nucl Med. 2017 Sep;58(9):1373-1379. doi: 10.2967/jnumed.117.190850. Epub 2017 Apr 27. J Nucl Med. 2017. PMID: 28450564 Free PMC article.

3

PET imaging of ⁶⁴Cu-DOTA-scFv-anti-PSMA lipid nanoparticles (LNPs): Enhanced tumor targeting over anti-PSMA scFv or untargeted LNPs.

Wong P, Li L, Chea J, Delgado MK, Crow D, Poku E, Szpikowska B, Bowles N, Channappa D, Colcher D, Wong JYC, Shively JE, Yazaki PJ. Wong P, et al. Among authors: colcher d. Nucl Med Biol. 2017 Apr;47:62-68. doi: 10.1016/j.nucmedbio.2017.01.004. Epub 2017 Jan 17. Nucl Med Biol. 2017. PMID: 28126683 Free PMC article.

4

Synthesis, Positron Emission Tomography Imaging, and Therapy of Diabody Targeted Drug Lipid Nanoparticles in a Prostate Cancer Murine Model.

Wong P, Li L, Chea J, Delgado MK, Poku E, Szpikowska B, Bowles N, Minnix M, Colcher D, Wong JYC, Shively JE, Yazaki PJ. Wong P, et al. Among authors: colcher d. Cancer Biother Radiopharm. 2017 Sep;32(7):247-257. doi: 10.1089/cbr.2017.2253. Cancer Biother Radiopharm. 2017. PMID: 28910151 Free PMC article.

5

Improved targeting of an anti-TAG-72 antibody drug conjugate for the treatment of ovarian cancer.

Minnix M, Li L, Yazaki P, Chea J, Poku E, Colcher D, Shively JE. Minnix M, et al. Among authors: colcher d. Cancer Med. 2020 Jul;9(13):4756-4767. doi: 10.1002/cam4.3078. Epub 2020 May 5. Cancer Med. 2020. PMID: 32368864 Free PMC article.

6

Pilot trial evaluating an 123I-labeled 80-kilodalton engineered anticarcinoembryonic antigen antibody fragment (cT84.66 minibody) in patients with colorectal cancer.

Wong JY, Chu DZ, Williams LE, Yamauchi DM, Ikle DN, Kwok CS, Liu A, Wilczynski S, Colcher D, Yazaki PJ, Shively JE, Wu AM, Raubitschek AA. Wong JY, et al. Among authors: colcher d. Clin Cancer Res. 2004 Aug 1;10(15):5014-21. doi: 10.1158/1078-0432.CCR-03-0576. Clin Cancer Res. 2004. PMID: 15297402 Clinical Trial.

7

Functional imaging of human epidermal growth factor receptor 2-positive metastatic breast cancer using (64)Cu-DOTA-trastuzumab PET.

Mortimer JE, Bading JR, Colcher DM, Conti PS, Frankel PH, Carroll MI, Tong S, Poku E, Miles JK, Shively JE, Raubitschek AA. Mortimer JE, et al. J Nucl Med. 2014 Jan;55(1):23-9. doi: 10.2967/jnumed.113.122630. Epub 2013 Dec 12. J Nucl Med. 2014. PMID: 24337604 Free PMC article.

8

Tumor Uptake of ⁶⁴Cu-DOTA-Trastuzumab in Patients with Metastatic Breast Cancer.

Mortimer JE, Bading JR, Park JM, Frankel PH, Carroll MI, Tran TT, Poku EK, Rockne RC, Raubitschek AA, Shively JE, Colcher DM. Mortimer JE, et al. J Nucl Med. 2018 Jan;59(1):38-43. doi: 10.2967/jnumed.117.193888. Epub 2017 Jun 21. J Nucl Med. 2018. PMID: 28637802 Free PMC article.

9

Use of ⁶⁴Cu-DOTA-Trastuzumab PET to Predict Response and Outcome of Patients Receiving Trastuzumab Emtansine for Metastatic Breast Cancer: A Pilot Study.

Mortimer JE, Bading JR, Frankel PH, Carroll MI, Yuan Y, Park JM, Tumyan L, Gidwaney N, Poku EK, Shively JE, Colcher DM. Mortimer JE, et al. Among authors: colcher dm. J Nucl Med. 2022 Aug;63(8):1145-1148. doi: 10.2967/jnumed.121.262940. Epub 2021 Dec 2. J Nucl Med. 2022. PMID: 34857660 Free PMC article.

10

First-In-Human Pilot PET Immunoimaging Study of ⁶⁴Cu-Anti-Carcinoembryonic Antigen Monoclonal Antibody (hT84.66-M5A) in Patients with Carcinoembryonic Antigen-Producing Cancers.

Wong JYC, Yamauchi DM, Adhikarla V, Simpson J, Frankel PH, Fong Y, Melstrom KA, Chen YJ, Salehian BD, Woo Y, Dandapani SV, Colcher DM, Poku EK, Yazaki PJ, Wu AM, Shively JE. Wong JYC, et al. Among authors: colcher dm. Cancer Biother Radiopharm. 2023 Feb;38(1):26-37. doi: 10.1089/cbr.2022.0028. Epub 2022 Sep 26. Cancer Biother Radiopharm. 2023. PMID: 36154291

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

202 results

Search Page